Crossmark

PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome

Crossref DOI link: https://doi.org/10.1038/s41375-024-02502-5

Published Online: 2024-12-19

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Caye-Eude, Aurélie https://orcid.org/0000-0001-5996-3037
Fazio, Grazia https://orcid.org/0000-0001-7077-8422
Pastorczak, Agata https://orcid.org/0000-0003-3089-6947
Boer, Judith M. https://orcid.org/0000-0003-4848-7789
Steinemann, Doris https://orcid.org/0000-0001-8797-0816
Ganguli, Debdutta

Sonneveld, Edwin

Haslinger, Sabrina

D’Andrea, Lucía

Bradtke, Jutta

Lopes, Bruno A. https://orcid.org/0000-0003-1072-470X
Zaliova, Marketa https://orcid.org/0000-0002-1639-7124
Escherich, Gabriele

König, Margit

Fortschegger, Klaus https://orcid.org/0000-0003-1276-0368
Inthal, Andrea

Stasevich, Irina

Emerenciano, Mariana https://orcid.org/0000-0003-2337-8420
Trka, Jan

Castillo, Luis

Parihar, Mayur https://orcid.org/0000-0002-8059-0914
Moorman, Anthony V. https://orcid.org/0000-0002-9781-6107
Bergmann, Anke K.

den Boer, Monique L. https://orcid.org/0000-0002-5795-2921
Młynarski, Wojciech https://orcid.org/0000-0003-2714-5851
Cazzaniga, Giovanni https://orcid.org/0000-0003-2955-4528
Cavé, Hélène https://orcid.org/0000-0003-2840-1511
Nebral, Karin https://orcid.org/0000-0002-0548-541X
Schinnerl, Dagmar https://orcid.org/0000-0003-4918-9302
Strehl, Sabine https://orcid.org/0000-0002-0179-0628
License Information

Text and Data Mining valid from 2024-12-19

Version of Record valid from 2024-12-19
More Information

Article History

Received: 18 October 2024

Revised: 28 November 2024

Accepted: 9 December 2024

First Online: 19 December 2024

Competing interests

: The authors declare no competing interests.

: This study was conducted in accordance with the ethical standards of the institutional and/or national research committees and with the ethical standards as laid down in the Declaration of Helsinki, and all methods were performed in accordance with the relevant guidelines and regulations. Patients were enrolled in an approved international or national clinical trial with written informed consent from their parents or legal guardians. The institutional review boards of the participating study groups approved the use of anonymized patient data for research purposes.

Document is current

Any future updates will be listed below